Aegerion Pharma (AEGR) Posts Q2 Loss of 49c, Misses Views
Tweet
Share
E-mailGet Alerts AEGR Hot Sheet
Join SI Premium – FREE
Aegerion Pharmaceuticals, Inc. (NASDAQ: AEGR) reported Q2 EPS of ($0.49), $0.09 worse than the analyst estimate of ($0.40).
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Freightos Limited (CRGO) Tops Q2 EPS by 3c ; Offers Guidance
- Seritage Growth Properties (SRG) Reports Q2 Loss of $0.13
- LeonaBio, Inc. (LONA) Tops Q2 EPS by 32c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
